 |
PDBsum entry 5nmf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
5nmf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
276 a.a.
|
|
|
|
|
|
|
|
|
|
|
99 a.a.
|
|
|
|
|
|
|
|
|
|
|
200 a.a.
|
|
|
|
|
|
|
|
|
|
|
239 a.a.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
|
|
|
| Name: |
|
Immune system
|
|
|
Title:
|
|
868 tcr in complex with hla a02 presenting slyntiatl
|
|
Structure:
|
|
Hla class i histocompatibility antigen, a-2 alpha chain. Chain: a, f. Synonym: mhc class i antigen a 2. Engineered: yes. Beta-2-microglobulin. Chain: b, g. Engineered: yes. Gag protein. Chain: c, h.
|
|
Source:
|
|
Homo sapiens. Human. Organism_taxid: 9606. Gene: hla-a, hlaa. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: b2m, cdabp0092, hdcma22p. Synthetic: yes. Human immunodeficiency virus 1.
|
|
Resolution:
|
|
|
2.89Å
|
R-factor:
|
0.196
|
R-free:
|
0.255
|
|
|
Authors:
|
|
P.J.Rizkallah,D.K.Cole,A.Fuller,A.K.Sewell
|
|
Key ref:
|
|
D.K.Cole
et al.
(2017).
Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.
Front Immunol,
8,
1503.
PubMed id:
|
|
|
Date:
|
|
|
05-Apr-17
|
Release date:
|
15-Nov-17
|
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
|
Headers
|
|
|
|
References
|
|
|
|
|
|
|
|
P04439
(1A03_HUMAN) -
HLA class I histocompatibility antigen, A alpha chain from Homo sapiens
|
|
|
|
Seq:
Struc:
|
|
|
|
365 a.a.
276 a.a.*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
P61769
(B2MG_HUMAN) -
Beta-2-microglobulin from Homo sapiens
|
|
|
|
Seq:
Struc:
|
|
|
|
119 a.a.
99 a.a.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
| |
|
|
Front Immunol
8:1503
(2017)
|
|
PubMed id:
|
|
|
|
|
|
| |
|
Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.
|
|
D.K.Cole,
A.Fuller,
G.Dolton,
E.Zervoudi,
M.Legut,
K.Miles,
L.Blanchfield,
F.Madura,
C.J.Holland,
A.M.Bulek,
J.S.Bridgeman,
J.J.Miles,
A.J.A.Schauenburg,
K.Beck,
B.D.Evavold,
P.J.Rizkallah,
A.K.Sewell.
|
|
|
|
|
| |
ABSTRACT
|
|
|
|
| |
|
|
Serial accumulation of mutations to fixation in the SLYNTVATL (SL9)
immunodominant, HIV p17 Gag-derived, HLA A2-restricted cytotoxic T lymphocyte
epitope produce the SLFNTIAVL triple mutant "ultimate" escape variant.
These mutations in solvent-exposed residues are believed to interfere with TCR
recognition, although confirmation has awaited structural verification. Here, we
solved a TCR co-complex structure with SL9 and the triple escape mutant to
determine the mechanism of immune escape in this eminent system. We show that,
in contrast to prevailing hypotheses, the main TCR contact residue is 4N and the
dominant mechanism of escape is notvialack of TCR engagement. Instead,
mutation of solvent-exposed residues in the peptide destabilise the peptide-HLA
and reduce peptide density at the cell surface. These results highlight the
extraordinary lengths that HIV employs to evade detection by high-affinity TCRs
with a broad peptide-binding footprint and necessitate re-evaluation of this
exemplar model of HIV TCR escape.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
| | |
Links
